| Literature DB >> 22996594 |
Marta Spodzieja1, Aneta Szymańska, Aleksandra Kołodziejczyk, Martyna Prądzińska, Martyna Maszota, Piotr Stefanowicz, Zbigniew Szewczuk, Anders Grubb, Paulina Czaplewska.
Abstract
Serum amyloid A (SAA) is a multifunctional acute-phase protein whose natural role seems to be participation in many physiologic and pathological processes. Prolonged increased SAA level in a number of chronic inflammatory and neoplastic diseases gives rise to reactive systemic amyloid A amyloidosis, where the N-terminal 76-amino acid residue-long segment of SAA is deposited as amyloid fibrils. Recently, a specific interaction between SAA and the ubiquitous inhibitor of cysteine proteases--human cystatin C (hCC)--has been described. Here, we report further evidence corroborating this interaction, and the identification of the SAA and hCC binding sites in the SAA-hCC complex, using a combination of selective proteolytic excision and high-resolution mass spectrometry. The shortest binding site in the SAA sequence was determined as SAA(86-104), whereas the binding site in hCC sequence was identified as hCC(96-102). Binding specificities of both interacting sequences were ascertained by affinity experiments (ELISA) and by registration of mass spectrum of SAA-hCC complex.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22996594 DOI: 10.1002/jmr.2220
Source DB: PubMed Journal: J Mol Recognit ISSN: 0952-3499 Impact factor: 2.137